Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 3Adenocarcinoma of Lung 3Squamous Cell Carcinoma of Head and Neck 2Mouth Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Barrett Esophagus 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Skin Neoplasms 1Salivary Gland Neoplasms 1Oropharyngeal Neoplasms 1Laryngeal Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Carcinoma, Basal Cell 1Adenocarcinoma, Follicular 1

Interventions

Biopsy 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2polyphenon E 1plecanatide 1linaclotide 1gluconic acid 1Specimen Handling 1Itraconazole 1Esomeprazole 1Erlotinib Hydrochloride 1Endoscopy, Digestive System 1Endoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Barrett Esophagus × 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a × Clear all
NCT01238042 2014-12-02

Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus

Roswell Park Cancer Institute

Phase 1 Completed
18 enrolled
Gastrointestinal

Barrett Esophagus

NCT01236443 2014-01-13

Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus

Roswell Park Cancer Institute

Phase 1 Completed
18 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡